Celltrion | 068270 - Interest Expense On Debt

Stock Price
195,800.00
Daily Change
500.00 0.26%
Monthly
-4.02%
Yearly
19.10%
Q2 Forecast
184,597.56

Celltrion reported KRW19B in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 4.83M 359.32M Dec/2025
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Celltrion KRW 19B 1.96B Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 12K 276.99M Dec/2025
Viatris USD 119.6M 0 Dec/2025
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025